Thus, Taylor and colleagues have shown that three important biochemical pathways, RAS/RAF, PI3K, and RB1, exhibit alterations in 34–43% of primary tumors and 74–100% of metastatic tumors [79]. The gene discussed is RB1; the disease is metastatic neoplasm.